NCT02838381View on ClinicalTrials.gov

Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer

NACompletedINTERVENTIONAL
Enrollment

553

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2023

Study Completion Date

June 11, 2024

Conditions
Metastatic Cancer
Interventions
OTHER

Additional biological samples

blood and tissue samples

Trial Locations (2)

Unknown

Centre Hospitalier Universitaire de Besançon, Besançon

Hôpital Nord Franche Comté, Montbéliard

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02838381 - Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer | Biotech Hunter | Biotech Hunter